{"DataElement":{"publicId":"13299113","version":"1","preferredName":"Childhood Cancer Toronto Guidelines Stage","preferredDefinition":"Cancer stage as captured by the Toronto Childhood Cancer Stage Guidelines.","longName":"13298748v1.00:13298956v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13298748","version":"1","preferredName":"Childhood Cancer Toronto Stage Guidelines","preferredDefinition":"A malignant neoplasm that occurs during childhood. Representative examples include acute leukemias, malignant brain neoplasms, and sarcomas.:A malignancy-specific staging system suitable for use by population registries for 16 of the most common childhood malignancies: acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, neuroblastoma, Wilms tumor, rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, osteosarcoma, Ewing sarcoma, retinoblastoma, hepatoblastoma, testicular and ovarian germ cell tumors, medulloblastoma, and ependymoma. The Guidelines include a two-tiered approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) and more detailed criteria for better-resourced registries (Tier 2). Tier 2 stage categories may be collapsed to Tier 1 categories to preserve comparability across registries. (http://www.iacr.com.fr/index.php?option=com_content&view=article&id=153&Itemid=657)","longName":"13298746v1.00:13298747v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"13298746","version":"1","preferredName":"Childhood Malignant Neoplasm","preferredDefinition":"A malignant neoplasm that occurs during childhood. Representative examples include acute leukemias, malignant brain neoplasms, and sarcomas.","longName":"C4005","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Childhood Malignant Neoplasm","conceptCode":"C4005","definition":"A malignant neoplasm that occurs during childhood. Representative examples include acute leukemias, malignant brain neoplasms, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F872B22D-301B-5042-E053-731AD00A9D7F","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-03","modifiedBy":"COLBERTM","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13298747","version":"1","preferredName":"Toronto Childhood Cancer Stage Guidelines","preferredDefinition":"A malignancy-specific staging system suitable for use by population registries for 16 of the most common childhood malignancies: acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, neuroblastoma, Wilms tumor, rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, osteosarcoma, Ewing sarcoma, retinoblastoma, hepatoblastoma, testicular and ovarian germ cell tumors, medulloblastoma, and ependymoma. The Guidelines include a two-tiered approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) and more detailed criteria for better-resourced registries (Tier 2). Tier 2 stage categories may be collapsed to Tier 1 categories to preserve comparability across registries. (http://www.iacr.com.fr/index.php?option=com_content&view=article&id=153&Itemid=657)","longName":"C197985","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toronto Childhood Cancer Stage Guidelines","conceptCode":"C197985","definition":"A malignancy-specific staging system suitable for use by population registries for 16 of the most common childhood malignancies: acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, neuroblastoma, Wilms tumor, rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, osteosarcoma, Ewing sarcoma, retinoblastoma, hepatoblastoma, testicular and ovarian germ cell tumors, medulloblastoma, and ependymoma. The Guidelines include a two-tiered approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) and more detailed criteria for better-resourced registries (Tier 2). Tier 2 stage categories may be collapsed to Tier 1 categories to preserve comparability across registries. (http://www.iacr.com.fr/index.php?option=com_content&view=article&id=153&Itemid=657)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F872B22D-301C-5042-E053-731AD00A9D7F","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-03","modifiedBy":"COLBERTM","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F872B22D-301D-5042-E053-731AD00A9D7F","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-03","modifiedBy":"COLBERTM","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":"4/3/23 Created per Patrick Dunn for CCDI SN 2165 entry. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13298956","version":"1","preferredName":"Toronto Childhood Cancer Guidelines Stage","preferredDefinition":"A malignancy-specific staging system suitable for use by population registries for 16 of the most common childhood malignancies: acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, neuroblastoma, Wilms tumor, rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, osteosarcoma, Ewing sarcoma, retinoblastoma, hepatoblastoma, testicular and ovarian germ cell tumors, medulloblastoma, and ependymoma. The Guidelines include a two-tiered approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) and more detailed criteria for better-resourced registries (Tier 2). Tier 2 stage categories may be collapsed to Tier 1 categories to preserve comparability across registries. (http://www.iacr.com.fr/index.php?option=com_content&view=article&id=153&Itemid=657)_The extent of a cancer in the body.","longName":"13298956v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Non-Hodgkin lymphoma Stage IV","valueDescription":null,"ValueMeaning":{"publicId":"13362507","version":"1","preferredName":"Stage IV Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2","longName":"13362507v1.00","preferredDefinition":"Initial CNS and/or bone marrow involvement. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2","conceptCode":"C198062","definition":"Initial CNS and/or bone marrow involvement. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E45D-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E467-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Neuroblastoma Stage L1","valueDescription":null,"ValueMeaning":{"publicId":"13362508","version":"1","preferredName":"Stage L1 Childhood Neuroblastoma by Toronto Guidelines v2","longName":"13362508v1.00","preferredDefinition":"Localized tumor that does not involve any vital structures as defined by the list of IDRFs (i.e., there are no IDRFs) and the tumor must be confined within one body compartment, neck, chest, abdomen, or pelvis. An intraspinal tumor extension that does not fulfill the criteria for an IDRF is consistent with stage L1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage L1 Childhood Neuroblastoma by Toronto Guidelines v2","conceptCode":"C198072","definition":"Localized tumor that does not involve any vital structures as defined by the list of IDRFs (i.e., there are no IDRFs) and the tumor must be confined within one body compartment, neck, chest, abdomen, or pelvis. An intraspinal tumor extension that does not fulfill the criteria for an IDRF is consistent with stage L1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E45E-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E468-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Neuroblastoma Stage L2","valueDescription":null,"ValueMeaning":{"publicId":"13362509","version":"1","preferredName":"Stage L2 Childhood Neuroblastoma by Toronto Guidelines v2","longName":"13362509v1.00","preferredDefinition":"Locoregional tumor with one or more IDRFs. The tumor may be ipsilateral contiguous within body compartments (i.e., a left-sided abdominal tumor with left-sided lung, bone or pleura involvement should be considered stage L2). However, a clearly left-sided abdominal tumor with right-sided lung, bone or pleura (or vice-versa) involvement is defined as metastatic disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage L2 Childhood Neuroblastoma by Toronto Guidelines v2","conceptCode":"C198073","definition":"Locoregional tumor with one or more IDRFs. The tumor may be ipsilateral contiguous within body compartments (i.e., a left-sided abdominal tumor with left-sided lung, bone or pleura involvement should be considered stage L2). However, a clearly left-sided abdominal tumor with right-sided lung, bone or pleura (or vice-versa) involvement is defined as metastatic disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E45F-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E469-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Neuroblastoma Stage M","valueDescription":null,"ValueMeaning":{"publicId":"13362510","version":"1","preferredName":"Stage M Childhood Neuroblastoma by Toronto Guidelines v2","longName":"13362510v1.00","preferredDefinition":"Distant metastatic disease (i.e., not contiguous with the primary tumor) except as defined for stage MS. Nonregional (distant) lymph node involvement is metastatic disease. However, an upper abdominal tumor with enlarged lower mediastinal nodes or a pelvic tumor with inguinal lymph node involvement is considered locoregional disease. Ascites and/or a pleural effusion, even with malignant cells, do not constitute metastatic disease unless they are remote from the body compartment of the primary tumor. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M Childhood Neuroblastoma by Toronto Guidelines v2","conceptCode":"C198074","definition":"Distant metastatic disease (i.e., not contiguous with the primary tumor) except as defined for stage MS. Nonregional (distant) lymph node involvement is metastatic disease. However, an upper abdominal tumor with enlarged lower mediastinal nodes or a pelvic tumor with inguinal lymph node involvement is considered locoregional disease. Ascites and/or a pleural effusion, even with malignant cells, do not constitute metastatic disease unless they are remote from the body compartment of the primary tumor. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E460-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E46A-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Renal tumor (excluding renal cell carcinomas) Stage I","valueDescription":null,"ValueMeaning":{"publicId":"13362512","version":"1","preferredName":"Stage I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children’s Oncology Group (COG) Protocol","longName":"13362512v1.00","preferredDefinition":"Tumor is limited to the kidney and completely excised. Renal capsule intact, not penetrated by tumor. No tumor invasion of veins or lymphatics of renal sinus. No nodal or hematogenous metastases. No prior biopsy. Negative margins. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol","conceptCode":"C198096","definition":"Tumor is limited to the kidney and completely excised. Renal capsule intact, not penetrated by tumor. No tumor invasion of veins or lymphatics of renal sinus. No nodal or hematogenous metastases. No prior biopsy. Negative margins. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E462-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E46B-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Renal tumor (excluding renal cell carcinomas) Stage II","valueDescription":null,"ValueMeaning":{"publicId":"13362513","version":"1","preferredName":"Stage II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children’s Oncology Group (COG) Protocol","longName":"13362513v1.00","preferredDefinition":"Tumor extends beyond kidney but completely resected. Tumor penetrates renal capsule. Tumor in lymphatics or veins of renal sinus. Tumor in renal vein with margin not involved. No nodal or hematogenous metastases. Negative margins. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol","conceptCode":"C198097","definition":"Tumor extends beyond kidney but completely resected. Tumor penetrates renal capsule. Tumor in lymphatics or veins of renal sinus. Tumor in renal vein with margin not involved. No nodal or hematogenous metastases. Negative margins. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E463-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E46C-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Renal tumor (excluding renal cell carcinomas) Stage III","valueDescription":null,"ValueMeaning":{"publicId":"13362514","version":"1","preferredName":"Stage III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children’s Oncology Group (COG) Protocol","longName":"13362514v1.00","preferredDefinition":"Residual tumor or nonhematogenous metastases confined to abdomen. Involved abdominal nodes. Peritoneal contamination or tumor implant. Tumor spillage of any degree occurring before or during surgery. Gross residual tumor in abdomen. Biopsy of tumor (including fine-needle aspiration) prior to removal of kidney. Resection margins involved by tumor. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol","conceptCode":"C198098","definition":"Residual tumor or nonhematogenous metastases confined to abdomen. Involved abdominal nodes. Peritoneal contamination or tumor implant. Tumor spillage of any degree occurring before or during surgery. Gross residual tumor in abdomen. Biopsy of tumor (including fine-needle aspiration) prior to removal of kidney. Resection margins involved by tumor. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E464-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E46D-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Renal tumor (excluding renal cell carcinomas) Stage IV","valueDescription":null,"ValueMeaning":{"publicId":"13362515","version":"1","preferredName":"Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children’s Oncology Group (COG) Protocol","longName":"13362515v1.00","preferredDefinition":"Hematogenous metastases or spread beyond abdomen at diagnosis. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol","conceptCode":"C198100","definition":"Hematogenous metastases or spread beyond abdomen at diagnosis. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E465-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E46E-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Renal tumor (excluding renal cell carcinomas) Stage y-I","valueDescription":null,"ValueMeaning":{"publicId":"13362516","version":"1","preferredName":"Stage y-I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol","longName":"13362516v1.00","preferredDefinition":"Tumor limited to kidney and completely resected. Renal capsule may be infiltrated by tumor, but tumor does not reach the outer surface. Tumor may protrude or bulge into the pelvic system or ureter but does not infiltrate. Vessel of renal sinus not involved. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage y-I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol","conceptCode":"C198081","definition":"Tumor limited to kidney and completely resected. Renal capsule may be infiltrated by tumor, but tumor does not reach the outer surface. Tumor may protrude or bulge into the pelvic system or ureter but does not infiltrate. Vessel of renal sinus not involved. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E466-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E46F-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Neuroblastoma Stage MS","valueDescription":null,"ValueMeaning":{"publicId":"13362511","version":"1","preferredName":"Stage MS Childhood Neuroblastoma by Toronto Guidelines v2","longName":"13362511v1.00","preferredDefinition":"Metastatic disease confined to skin, liver, and/or bone marrow, in a patient less than 18 months (547 days). MIBG scintigraphy must be negative in bone and bone marrow. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage MS Childhood Neuroblastoma by Toronto Guidelines v2","conceptCode":"C198075","definition":"Metastatic disease confined to skin, liver, and/or bone marrow, in a patient less than 18 months (547 days). MIBG scintigraphy must be negative in bone and bone marrow. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E461-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E470-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Acute lymphoblastic leukemia CNS1","valueDescription":null,"ValueMeaning":{"publicId":"13362497","version":"1","preferredName":"Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2","longName":"13362497v1.00","preferredDefinition":"No clinical signs of CNS involvement and no blasts in CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2","conceptCode":"C198036","definition":"No clinical signs of CNS involvement and no blasts in CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E453-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E471-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Acute lymphoblastic leukemia CNS2","valueDescription":null,"ValueMeaning":{"publicId":"13362498","version":"1","preferredName":"Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2","longName":"13362498v1.00","preferredDefinition":"No clinical signs of CNS involvement and blasts in CSF and either: WBC < 5/μL CSF or WBC > or = 5/uL CSF and RBC > or = 10/uL CSF and WBC/RBC in CSF < or = 2x WBC/RBC in blood. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2","conceptCode":"C198039","definition":"No clinical signs of CNS involvement and blasts in CSF and either: WBC < 5/μL CSF or WBC > or = 5/uL CSF and RBC > or = 10/uL CSF and WBC/RBC in CSF < or = 2x WBC/RBC in blood. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E454-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E472-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Acute lymphoblastic leukemia CNS3","valueDescription":null,"ValueMeaning":{"publicId":"13362499","version":"1","preferredName":"Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2","longName":"13362499v1.00","preferredDefinition":"Clinical signs of CNS involvement or blasts in CSF and WBC > or = 5/uL CSF and either: RBC < 10/uL CSF or RBC > or = 10/uL CSF and WBC/RBC in CSF > 2x WBC/RBC in blood. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2","conceptCode":"C198040","definition":"Clinical signs of CNS involvement or blasts in CSF and WBC > or = 5/uL CSF and either: RBC < 10/uL CSF or RBC > or = 10/uL CSF and WBC/RBC in CSF > 2x WBC/RBC in blood. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E455-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E473-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hodgkin lymphoma Stage I","valueDescription":null,"ValueMeaning":{"publicId":"13362500","version":"1","preferredName":"Stage I Childhood Hodgkin Lymphoma by Toronto Guidelines v2","longName":"13362500v1.00","preferredDefinition":"Involvement of a single lymph node region or involvement of a single extra-lymphatic organ or site, without lymph node involvement. This definition applies to both tiers (tier 1 and 2).  (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Childhood Hodgkin Lymphoma by Toronto Guidelines v2","conceptCode":"C198042","definition":"Involvement of a single lymph node region or involvement of a single extra-lymphatic organ or site, without lymph node involvement. This definition applies to both tiers (tier 1 and 2).  (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E456-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E474-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hodgkin lymphoma Stage III","valueDescription":null,"ValueMeaning":{"publicId":"13362502","version":"1","preferredName":"Stage III Childhood Hodgkin Lymphoma by Toronto Guidelines v2","longName":"13362502v1.00","preferredDefinition":"Involvement of lymph node regions on both sides (above and below) of the diaphragm. This may be accompanied by extra-lymphatic extension in association with adjacent lymph node involvement (i.e., local extension from a lymph node area into a nearby organ) and/or involvement of spleen. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Childhood Hodgkin Lymphoma by Toronto Guidelines v2","conceptCode":"C198048","definition":"Involvement of lymph node regions on both sides (above and below) of the diaphragm. This may be accompanied by extra-lymphatic extension in association with adjacent lymph node involvement (i.e., local extension from a lymph node area into a nearby organ) and/or involvement of spleen. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E458-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E475-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hodgkin lymphoma Stage IV","valueDescription":null,"ValueMeaning":{"publicId":"13362503","version":"1","preferredName":"Stage IV Childhood Hodgkin Lymphoma by Toronto Guidelines v2","longName":"13362503v1.00","preferredDefinition":"Diffuse or disseminated (multifocal) involvement of one or more extra-lymphatic organs with or without associated lymph node involvement or isolated (non-contiguous) extra-lymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s) or any involvement of liver, bone marrow, lungs (except by direct extension from another site) or CSF. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Childhood Hodgkin Lymphoma by Toronto Guidelines v2","conceptCode":"C198051","definition":"Diffuse or disseminated (multifocal) involvement of one or more extra-lymphatic organs with or without associated lymph node involvement or isolated (non-contiguous) extra-lymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s) or any involvement of liver, bone marrow, lungs (except by direct extension from another site) or CSF. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E459-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E476-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Non-Hodgkin lymphoma Stage I","valueDescription":null,"ValueMeaning":{"publicId":"13362504","version":"1","preferredName":"Stage I Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2","longName":"13362504v1.00","preferredDefinition":"Involvement of a single tumor mass or nodal area, excluding the abdomen and mediastinum. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2","conceptCode":"C198059","definition":"Involvement of a single tumor mass or nodal area, excluding the abdomen and mediastinum. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E45A-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E477-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Non-Hodgkin lymphoma Stage II","valueDescription":null,"ValueMeaning":{"publicId":"13362505","version":"1","preferredName":"Stage II Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2","longName":"13362505v1.00","preferredDefinition":"A single tumor (extranodal) with regional node involvement or two or more nodal areas on the same side (either above or below) of the diaphragm or two or more single (extranodal) tumors, with or without regional node involvement, on the same side (either above or below) of the diaphragm or a completely resected primary gastrointestinal tract tumor with or without involvement of associated mesenteric nodes only. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2","conceptCode":"C198060","definition":"A single tumor (extranodal) with regional node involvement or two or more nodal areas on the same side (either above or below) of the diaphragm or two or more single (extranodal) tumors, with or without regional node involvement, on the same side (either above or below) of the diaphragm or a completely resected primary gastrointestinal tract tumor with or without involvement of associated mesenteric nodes only. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E45B-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E478-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Non-Hodgkin lymphoma Stage III","valueDescription":null,"ValueMeaning":{"publicId":"13362506","version":"1","preferredName":"Stage III Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2","longName":"13362506v1.00","preferredDefinition":"Tumors (extranodal) or nodal areas on both sides (above and below) of the diaphragm or any primary intrathoracic tumors (mediastinal, hilar, pulmonary, pleural, or thymic) or extensive (unresectable) primary intra-abdominal disease or any paraspinal or epidural tumors regardless of other tumor sites. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2","conceptCode":"C198061","definition":"Tumors (extranodal) or nodal areas on both sides (above and below) of the diaphragm or any primary intrathoracic tumors (mediastinal, hilar, pulmonary, pleural, or thymic) or extensive (unresectable) primary intra-abdominal disease or any paraspinal or epidural tumors regardless of other tumor sites. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E45C-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E479-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hodgkin lymphoma Stage II","valueDescription":null,"ValueMeaning":{"publicId":"13362501","version":"1","preferredName":"Stage II Childhood Hodgkin Lymphoma by Toronto Guidelines v2","longName":"13362501v1.00","preferredDefinition":"Involvement of two or more lymph node regions on the same side (either above or below) of the diaphragm or localized involvement of a single extra-lymphatic organ or site in association with regional lymph node involvement (i.e., local extension from a lymph node area into a nearby organ), with or without involvement of other contiguous lymph node regions on the same side (either above or below) of the diaphragm. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Childhood Hodgkin Lymphoma by Toronto Guidelines v2","conceptCode":"C198045","definition":"Involvement of two or more lymph node regions on the same side (either above or below) of the diaphragm or localized involvement of a single extra-lymphatic organ or site in association with regional lymph node involvement (i.e., local extension from a lymph node area into a nearby organ), with or without involvement of other contiguous lymph node regions on the same side (either above or below) of the diaphragm. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988A285-E457-0440-E053-731AD00A9CB7","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988A285-E47A-0440-E053-731AD00A9CB7","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Renal tumor (excluding renal cell carcinomas) Stage y-II","valueDescription":null,"ValueMeaning":{"publicId":"13362543","version":"1","preferredName":"Stage y-II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol","longName":"13362543v1.00","preferredDefinition":"Tumor extends beyond kidney but completely resected. Tumor penetrates renal capsule into perirenal fat. Tumor infiltrates the renal sinus and/or invades blood and lymphatic vessels outside renal parenchyma but is completely resected. Tumor infiltrates adjacent organs or vena cava but is completely resected. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage y-II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol","conceptCode":"C198082","definition":"Tumor extends beyond kidney but completely resected. Tumor penetrates renal capsule into perirenal fat. Tumor infiltrates the renal sinus and/or invades blood and lymphatic vessels outside renal parenchyma but is completely resected. Tumor infiltrates adjacent organs or vena cava but is completely resected. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B712-5D1D-06D5-E053-731AD00A15DF","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B712-5D25-06D5-E053-731AD00A15DF","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Renal tumor (excluding renal cell carcinomas) Stage y-III","valueDescription":null,"ValueMeaning":{"publicId":"13362544","version":"1","preferredName":"Stage y-III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol","longName":"13362544v1.00","preferredDefinition":"Incomplete excision of the tumor (gross or microscopic extension beyond the resection margins). Involved abdominal lymph nodes, including necrotic tumor or chemotherapy-induced changes. Tumor rupture before or intraoperatively. Tumor has penetrated the peritoneal surface. Tumor thrombi present at resection margins. Surgical biopsy prior to resection (does not include needle biopsy). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage y-III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol","conceptCode":"C198083","definition":"Incomplete excision of the tumor (gross or microscopic extension beyond the resection margins). Involved abdominal lymph nodes, including necrotic tumor or chemotherapy-induced changes. Tumor rupture before or intraoperatively. Tumor has penetrated the peritoneal surface. Tumor thrombi present at resection margins. Surgical biopsy prior to resection (does not include needle biopsy). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B712-5D1E-06D5-E053-731AD00A15DF","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B712-5D26-06D5-E053-731AD00A15DF","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Renal tumor (excluding renal cell carcinomas) Stage IV","valueDescription":null,"ValueMeaning":{"publicId":"13362545","version":"1","preferredName":"Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol","longName":"13362545v1.00","preferredDefinition":"Hematogenous metastases or spread beyond abdomen at diagnosis. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol","conceptCode":"C198084","definition":"Hematogenous metastases or spread beyond abdomen at diagnosis. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B712-5D1F-06D5-E053-731AD00A15DF","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B712-5D27-06D5-E053-731AD00A15DF","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma Stage II","valueDescription":null,"ValueMeaning":{"publicId":"13362547","version":"1","preferredName":"Stage II Childhood Rhabdomyosarcoma by Toronto Guidelines v2","longName":"13362547v1.00","preferredDefinition":"Unfavorable site and T1a, T2a, N0, M0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Childhood Rhabdomyosarcoma by Toronto Guidelines v2","conceptCode":"C198157","definition":"Unfavorable site and T1a, T2a, N0, M0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B712-5D21-06D5-E053-731AD00A15DF","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B712-5D28-06D5-E053-731AD00A15DF","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma Stage III","valueDescription":null,"ValueMeaning":{"publicId":"13362548","version":"1","preferredName":"Stage III Childhood Rhabdomyosarcoma by Toronto Guidelines v2","longName":"13362548v1.00","preferredDefinition":"Unfavorable site and (T1a, T2a, N1, M0); (T1b, T2b, Any N, M0). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Childhood Rhabdomyosarcoma by Toronto Guidelines v2","conceptCode":"C198158","definition":"Unfavorable site and (T1a, T2a, N1, M0); (T1b, T2b, Any N, M0). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B712-5D22-06D5-E053-731AD00A15DF","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B712-5D29-06D5-E053-731AD00A15DF","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma Stage IV","valueDescription":null,"ValueMeaning":{"publicId":"13362549","version":"1","preferredName":"Stage IV Childhood Rhabdomyosarcoma by Toronto Guidelines v2","longName":"13362549v1.00","preferredDefinition":"Any site and any T, any N, M1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Childhood Rhabdomyosarcoma by Toronto Guidelines v2","conceptCode":"C198159","definition":"Any site and any T, any N, M1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B712-5D23-06D5-E053-731AD00A15DF","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B712-5D2A-06D5-E053-731AD00A15DF","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Non-rhabdomyosarcoma soft tissue sarcoma Stage I","valueDescription":null,"ValueMeaning":{"publicId":"13362550","version":"1","preferredName":"Stage I Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2","longName":"13362550v1.00","preferredDefinition":"Any T, N0, M0, G1 or GX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2","conceptCode":"C198165","definition":"Any T, N0, M0, G1 or GX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B712-5D24-06D5-E053-731AD00A15DF","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B712-5D2B-06D5-E053-731AD00A15DF","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma Stage I","valueDescription":null,"ValueMeaning":{"publicId":"13362546","version":"1","preferredName":"Stage I Childhood Rhabdomyosarcoma by Toronto Guidelines v2","longName":"13362546v1.00","preferredDefinition":"Favorable site and any T, any N, M0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Childhood Rhabdomyosarcoma by Toronto Guidelines v2","conceptCode":"C198156","definition":"Favorable site and any T, any N, M0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B712-5D20-06D5-E053-731AD00A15DF","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B712-5D2C-06D5-E053-731AD00A15DF","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Non-rhabdomyosarcoma soft tissue sarcoma Stage II","valueDescription":null,"ValueMeaning":{"publicId":"13362551","version":"1","preferredName":"Stage II Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2","longName":"13362551v1.00","preferredDefinition":"T1, N0, M0, G2 or G3. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2","conceptCode":"C198166","definition":"T1, N0, M0, G2 or G3. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B97B-FB7E-071A-E053-731AD00A169D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B97B-FB85-071A-E053-731AD00A169D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Non-rhabdomyosarcoma soft tissue sarcoma Stage III","valueDescription":null,"ValueMeaning":{"publicId":"13362552","version":"1","preferredName":"Stage III Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2","longName":"13362552v1.00","preferredDefinition":"T2 or T3 or T4, N0, M0, G2 or G3 or Any T, N1, M0, Any G (G1, G2, G3 or GX). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2","conceptCode":"C198167","definition":"T2 or T3 or T4, N0, M0, G2 or G3 or Any T, N1, M0, Any G (G1, G2, G3 or GX). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B97B-FB7F-071A-E053-731AD00A169D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B97B-FB86-071A-E053-731AD00A169D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Malignant bone tumor Localized","valueDescription":null,"ValueMeaning":{"publicId":"13362554","version":"1","preferredName":"Localized Childhood Malignant Bone Neoplasm by Toronto Guidelines v2","longName":"13362554v1.00","preferredDefinition":"Tumor confined to the area of origin including the regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Localized Childhood Malignant Bone Neoplasm by Toronto Guidelines v2","conceptCode":"C198172","definition":"Tumor confined to the area of origin including the regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B97B-FB81-071A-E053-731AD00A169D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B97B-FB87-071A-E053-731AD00A169D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Malignant bone tumor Metastatic","valueDescription":null,"ValueMeaning":{"publicId":"13362555","version":"1","preferredName":"Metastatic Childhood Malignant Bone Neoplasm by Toronto Guidelines v2","longName":"13362555v1.00","preferredDefinition":"Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Childhood Malignant Bone Neoplasm by Toronto Guidelines v2","conceptCode":"C198173","definition":"Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B97B-FB82-071A-E053-731AD00A169D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B97B-FB88-071A-E053-731AD00A169D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Retinoblastoma Stage 0","valueDescription":null,"ValueMeaning":{"publicId":"13362556","version":"1","preferredName":"Stage 0 Childhood Retinoblastoma by Toronto Guidelines v2","longName":"13362556v1.00","preferredDefinition":"The tumor is confined to the globe. Enucleation has not been performed. (The patient is treated \"conservatively\" with either focal therapies or chemotherapy.) (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Childhood Retinoblastoma by Toronto Guidelines v2","conceptCode":"C198180","definition":"The tumor is confined to the globe. Enucleation has not been performed. (The patient is treated \"conservatively\" with either focal therapies or chemotherapy.) (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B97B-FB83-071A-E053-731AD00A169D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B97B-FB89-071A-E053-731AD00A169D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Retinoblastoma Stage I","valueDescription":null,"ValueMeaning":{"publicId":"13362557","version":"1","preferredName":"Stage I Childhood Retinoblastoma by Toronto Guidelines v2","longName":"13362557v1.00","preferredDefinition":"Enucleation with negative margins. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Childhood Retinoblastoma by Toronto Guidelines v2","conceptCode":"C198181","definition":"Enucleation with negative margins. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B97B-FB84-071A-E053-731AD00A169D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B97B-FB8A-071A-E053-731AD00A169D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Non-rhabdomyosarcoma soft tissue sarcoma Stage IV","valueDescription":null,"ValueMeaning":{"publicId":"13362553","version":"1","preferredName":"Stage IV Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2","longName":"13362553v1.00","preferredDefinition":"Any T, Any N, M1, Any G (G1, G2, G3, GX). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2","conceptCode":"C198168","definition":"Any T, Any N, M1, Any G (G1, G2, G3, GX). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988B97B-FB80-071A-E053-731AD00A169D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988B97B-FB8B-071A-E053-731AD00A169D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Retinoblastoma Stage II","valueDescription":null,"ValueMeaning":{"publicId":"13362569","version":"1","preferredName":"Stage II Childhood Retinoblastoma by Toronto Guidelines v2","longName":"13362569v1.00","preferredDefinition":"Enucleation with microscopic residual disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Childhood Retinoblastoma by Toronto Guidelines v2","conceptCode":"C198182","definition":"Enucleation with microscopic residual disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988BE19-C145-07A5-E053-731AD00AEE0D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988BE19-C14B-07A5-E053-731AD00AEE0D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Retinoblastoma Stage III","valueDescription":null,"ValueMeaning":{"publicId":"13362570","version":"1","preferredName":"Stage III Childhood Retinoblastoma by Toronto Guidelines v2","longName":"13362570v1.00","preferredDefinition":"Regional extension: involvement of the orbit and/or preauricular or cervical lymph node extension. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Childhood Retinoblastoma by Toronto Guidelines v2","conceptCode":"C198183","definition":"Regional extension: involvement of the orbit and/or preauricular or cervical lymph node extension. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988BE19-C146-07A5-E053-731AD00AEE0D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988BE19-C14C-07A5-E053-731AD00AEE0D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hepatoblastoma Localized PRETEXT I","valueDescription":null,"ValueMeaning":{"publicId":"13362572","version":"1","preferredName":"Localized PRETEX I Hepatoblastoma","longName":"13362572v1.00","preferredDefinition":"PRETEX I hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Localized PRETEX I Hepatoblastoma","conceptCode":"C198011","definition":"PRETEX I hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988BE19-C148-07A5-E053-731AD00AEE0D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988BE19-C14D-07A5-E053-731AD00AEE0D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hepatoblastoma Localized PRETEXT II","valueDescription":null,"ValueMeaning":{"publicId":"13362573","version":"1","preferredName":"Localized PRETEX II Hepatoblastoma","longName":"13362573v1.00","preferredDefinition":"PRETEX II hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Localized PRETEX II Hepatoblastoma","conceptCode":"C198012","definition":"PRETEX II hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988BE19-C149-07A5-E053-731AD00AEE0D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988BE19-C14E-07A5-E053-731AD00AEE0D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hepatoblastoma Localized PRETEXT III","valueDescription":null,"ValueMeaning":{"publicId":"13362574","version":"1","preferredName":"Localized PRETEX III Hepatoblastoma","longName":"13362574v1.00","preferredDefinition":"PRETEX III hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Localized PRETEX III Hepatoblastoma","conceptCode":"C198013","definition":"PRETEX III hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988BE19-C14A-07A5-E053-731AD00AEE0D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988BE19-C14F-07A5-E053-731AD00AEE0D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Retinoblastoma Stage IV","valueDescription":null,"ValueMeaning":{"publicId":"13362571","version":"1","preferredName":"Stage IV Childhood Retinoblastoma by Toronto Guidelines v2","longName":"13362571v1.00","preferredDefinition":"Distant metastatic disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Childhood Retinoblastoma by Toronto Guidelines v2","conceptCode":"C198185","definition":"Distant metastatic disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988BE19-C147-07A5-E053-731AD00AEE0D","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988BE19-C150-07A5-E053-731AD00AEE0D","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hepatoblastoma Localized PRETEXT IV","valueDescription":null,"ValueMeaning":{"publicId":"13362575","version":"1","preferredName":"Localized PRETEX IV Hepatoblastoma","longName":"13362575v1.00","preferredDefinition":"PRETEX IV hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Localized PRETEX IV Hepatoblastoma","conceptCode":"C198014","definition":"PRETEX IV hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988C01F-46AE-07E4-E053-731AD00AA738","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988C01F-46B3-07E4-E053-731AD00AA738","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hepatoblastoma Metastatic PRETEXT I","valueDescription":null,"ValueMeaning":{"publicId":"13362576","version":"1","preferredName":"Metastatic PRETEX I Hepatoblastoma","longName":"13362576v1.00","preferredDefinition":"PRETEX I hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic PRETEX I Hepatoblastoma","conceptCode":"C198015","definition":"PRETEX I hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988C01F-46AF-07E4-E053-731AD00AA738","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988C01F-46B4-07E4-E053-731AD00AA738","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hepatoblastoma Metastatic PRETEXT II","valueDescription":null,"ValueMeaning":{"publicId":"13362577","version":"1","preferredName":"Metastatic PRETEX II Hepatoblastoma","longName":"13362577v1.00","preferredDefinition":"PRETEX II hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic PRETEX II Hepatoblastoma","conceptCode":"C198016","definition":"PRETEX II hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988C01F-46B0-07E4-E053-731AD00AA738","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988C01F-46B5-07E4-E053-731AD00AA738","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hepatoblastoma Metastatic PRETEXT III","valueDescription":null,"ValueMeaning":{"publicId":"13362578","version":"1","preferredName":"Metastatic PRETEX III Hepatoblastoma","longName":"13362578v1.00","preferredDefinition":"PRETEX III hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic PRETEX III Hepatoblastoma","conceptCode":"C198017","definition":"PRETEX III hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988C01F-46B1-07E4-E053-731AD00AA738","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988C01F-46B6-07E4-E053-731AD00AA738","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Hepatoblastoma Metastatic PRETEXT IV","valueDescription":null,"ValueMeaning":{"publicId":"13362579","version":"1","preferredName":"Metastatic PRETEX IV Hepatoblastoma","longName":"13362579v1.00","preferredDefinition":"PRETEX IV hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic PRETEX IV Hepatoblastoma","conceptCode":"C198018","definition":"PRETEX IV hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988C01F-46B2-07E4-E053-731AD00AA738","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988C01F-46B7-07E4-E053-731AD00AA738","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage IA","valueDescription":null,"ValueMeaning":{"publicId":"13367898","version":"1","preferredName":"Stage IA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367898v1.00","preferredDefinition":"pT1, N0, M0, S0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198420","definition":"pT1, N0, M0, S0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C6FA-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C704-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage IB","valueDescription":null,"ValueMeaning":{"publicId":"13367899","version":"1","preferredName":"Stage IB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367899v1.00","preferredDefinition":"pT2-4, N0, M0, S0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198421","definition":"pT2-4, N0, M0, S0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C6FB-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C705-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage IS","valueDescription":null,"ValueMeaning":{"publicId":"13367900","version":"1","preferredName":"Stage IS Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367900v1.00","preferredDefinition":"Any pT, N0, M0, S1-3. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IS Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198423","definition":"Any pT, N0, M0, S1-3. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C6FC-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C706-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage II","valueDescription":null,"ValueMeaning":{"publicId":"13367901","version":"1","preferredName":"Stage II Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367901v1.00","preferredDefinition":"Any pT, N1-3, M0, SX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198424","definition":"Any pT, N1-3, M0, SX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C6FD-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C707-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage IIB","valueDescription":null,"ValueMeaning":{"publicId":"13367903","version":"1","preferredName":"Stage IIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367903v1.00","preferredDefinition":"Any pT, N2, M0, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198426","definition":"Any pT, N2, M0, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C6FF-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C708-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage IIC","valueDescription":null,"ValueMeaning":{"publicId":"13367904","version":"1","preferredName":"Stage IIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367904v1.00","preferredDefinition":"Any pT, N3, M0, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198427","definition":"Any pT, N3, M0, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C700-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C709-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage III","valueDescription":null,"ValueMeaning":{"publicId":"13367905","version":"1","preferredName":"Stage III Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367905v1.00","preferredDefinition":"Any pT, Any N, M1, SX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198428","definition":"Any pT, Any N, M1, SX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C701-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C70A-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage IIIA","valueDescription":null,"ValueMeaning":{"publicId":"13367906","version":"1","preferredName":"Stage IIIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367906v1.00","preferredDefinition":"Any pT, Any N, M1, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198429","definition":"Any pT, Any N, M1, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C702-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C70B-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage IIIB","valueDescription":null,"ValueMeaning":{"publicId":"13367907","version":"1","preferredName":"Stage IIIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367907v1.00","preferredDefinition":"Any pT, N1-N3, M0, S2 or Any pT, Any N, M1, S2. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198430","definition":"Any pT, N1-N3, M0, S2 or Any pT, Any N, M1, S2. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C703-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C70C-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage IIA","valueDescription":null,"ValueMeaning":{"publicId":"13367902","version":"1","preferredName":"Stage IIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367902v1.00","preferredDefinition":"Any pT, N1, M0, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198425","definition":"Any pT, N1, M0, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988DD7E-C6FE-0FCE-E053-731AD00A9F52","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988DD7E-C70D-0FCE-E053-731AD00A9F52","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage IIIC","valueDescription":null,"ValueMeaning":{"publicId":"13367908","version":"1","preferredName":"Stage IIIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367908v1.00","preferredDefinition":"Any pT, N1-N3, M0, S3 or Any pT, Any N, M1, S3. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198432","definition":"Any pT, N1-N3, M0, S3 or Any pT, Any N, M1, S3. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63D2-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63DC-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ovarian germ cell tumor Stage I","valueDescription":null,"ValueMeaning":{"publicId":"13367909","version":"1","preferredName":"Stage I Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2","longName":"13367909v1.00","preferredDefinition":"Tumor confined to ovaries (one or both). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198446","definition":"Tumor confined to ovaries (one or both). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63D3-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63DD-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ovarian germ cell tumor Stage II","valueDescription":null,"ValueMeaning":{"publicId":"13367910","version":"1","preferredName":"Stage II Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2","longName":"13367910v1.00","preferredDefinition":"Tumor involves one or both ovaries with pelvic extension (below the pelvic brim). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198447","definition":"Tumor involves one or both ovaries with pelvic extension (below the pelvic brim). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63D4-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63DE-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ovarian germ cell tumor Stage III","valueDescription":null,"ValueMeaning":{"publicId":"13367911","version":"1","preferredName":"Stage III Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2","longName":"13367911v1.00","preferredDefinition":"Tumor involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198448","definition":"Tumor involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63D5-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63DF-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Astrocytomas Localized","valueDescription":null,"ValueMeaning":{"publicId":"13367913","version":"1","preferredName":"Localized Childhood Astrocytoma by Toronto Guidelines v2","longName":"13367913v1.00","preferredDefinition":"Localized disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Localized Childhood Astrocytoma by Toronto Guidelines v2","conceptCode":"C198451","definition":"Localized disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63D7-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63E0-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Astrocytomas Metastatic","valueDescription":null,"ValueMeaning":{"publicId":"13367914","version":"1","preferredName":"Metastatic Childhood Astrocytoma by Toronto Guidelines v2","longName":"13367914v1.00","preferredDefinition":"Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Childhood Astrocytoma by Toronto Guidelines v2","conceptCode":"C198452","definition":"Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63D8-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63E1-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Medulloblastoma M0","valueDescription":null,"ValueMeaning":{"publicId":"13367915","version":"1","preferredName":"Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2","longName":"13367915v1.00","preferredDefinition":"No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2","conceptCode":"C198479","definition":"No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63D9-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63E2-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Medulloblastoma M1","valueDescription":null,"ValueMeaning":{"publicId":"13367916","version":"1","preferredName":"Stage M1 Childhood Medulloblastoma by Toronto Guidelines v2","longName":"13367916v1.00","preferredDefinition":"Tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M1 Childhood Medulloblastoma by Toronto Guidelines v2","conceptCode":"C198480","definition":"Tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63DA-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63E3-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Medulloblastoma M2","valueDescription":null,"ValueMeaning":{"publicId":"13367917","version":"1","preferredName":"Stage M2 Childhood Medulloblastoma by Toronto Guidelines v2","longName":"13367917v1.00","preferredDefinition":"Visible metastasis in brain. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M2 Childhood Medulloblastoma by Toronto Guidelines v2","conceptCode":"C198481","definition":"Visible metastasis in brain. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63DB-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63E4-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ovarian germ cell tumor Stage IV","valueDescription":null,"ValueMeaning":{"publicId":"13367912","version":"1","preferredName":"Stage IV Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2","longName":"13367912v1.00","preferredDefinition":"Distant metastasis (excludes peritoneal metastases). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198449","definition":"Distant metastasis (excludes peritoneal metastases). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988EF98-63D6-120E-E053-731AD00A92E8","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988EF98-63E5-120E-E053-731AD00A92E8","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Medulloblastoma M3","valueDescription":null,"ValueMeaning":{"publicId":"13367918","version":"1","preferredName":"Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2","longName":"13367918v1.00","preferredDefinition":"Visible metastasis in spine or visible metastasis in cervicomedullary junction. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2","conceptCode":"C198482","definition":"Visible metastasis in spine or visible metastasis in cervicomedullary junction. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988F5D4-0D24-12B0-E053-731AD00A57AC","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988F5D4-0D2B-12B0-E053-731AD00A57AC","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Medulloblastoma M4","valueDescription":null,"ValueMeaning":{"publicId":"13367919","version":"1","preferredName":"Stage M4 Childhood Medulloblastoma by Toronto Guidelines v2","longName":"13367919v1.00","preferredDefinition":"Metastasis outside of the central nervous system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M4 Childhood Medulloblastoma by Toronto Guidelines v2","conceptCode":"C198483","definition":"Metastasis outside of the central nervous system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988F5D4-0D25-12B0-E053-731AD00A57AC","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988F5D4-0D2C-12B0-E053-731AD00A57AC","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ependymoma M1","valueDescription":null,"ValueMeaning":{"publicId":"13367921","version":"1","preferredName":"Stage M1 Childhood Ependymoma by Toronto Guidelines v2","longName":"13367921v1.00","preferredDefinition":"Tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M1 Childhood Ependymoma by Toronto Guidelines v2","conceptCode":"C198490","definition":"Tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988F5D4-0D27-12B0-E053-731AD00A57AC","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988F5D4-0D2D-12B0-E053-731AD00A57AC","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ependymoma M2","valueDescription":null,"ValueMeaning":{"publicId":"13367922","version":"1","preferredName":"Stage M2 Childhood Ependymoma by Toronto Guidelines v2","longName":"13367922v1.00","preferredDefinition":"Visible metastasis in brain. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M2 Childhood Ependymoma by Toronto Guidelines v2","conceptCode":"C198491","definition":"Visible metastasis in brain. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988F5D4-0D28-12B0-E053-731AD00A57AC","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988F5D4-0D2E-12B0-E053-731AD00A57AC","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ependymoma M3","valueDescription":null,"ValueMeaning":{"publicId":"13367923","version":"1","preferredName":"Stage M3 Childhood Ependymoma by Toronto Guidelines v2","longName":"13367923v1.00","preferredDefinition":"Visible metastasis in spine or visible metastasis in cervicomedullary junction. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M3 Childhood Ependymoma by Toronto Guidelines v2","conceptCode":"C198492","definition":"Visible metastasis in spine or visible metastasis in cervicomedullary junction. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988F5D4-0D29-12B0-E053-731AD00A57AC","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988F5D4-0D2F-12B0-E053-731AD00A57AC","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ependymoma M4","valueDescription":null,"ValueMeaning":{"publicId":"13367924","version":"1","preferredName":"Stage M4 Childhood Ependymoma by Toronto Guidelines v2","longName":"13367924v1.00","preferredDefinition":"Metastasis outside of the central nervous system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M4 Childhood Ependymoma by Toronto Guidelines v2","conceptCode":"C198493","definition":"Metastasis outside of the central nervous system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988F5D4-0D2A-12B0-E053-731AD00A57AC","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988F5D4-0D30-12B0-E053-731AD00A57AC","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Ependymoma M0","valueDescription":null,"ValueMeaning":{"publicId":"13367920","version":"1","preferredName":"Stage M0 Childhood Ependymoma by Toronto Guidelines v2","longName":"13367920v1.00","preferredDefinition":"No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M0 Childhood Ependymoma by Toronto Guidelines v2","conceptCode":"C198489","definition":"No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F988F5D4-0D26-12B0-E053-731AD00A57AC","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F988F5D4-0D31-12B0-E053-731AD00A57AC","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"},{"value":"Testicular germ cell tumor Stage I","valueDescription":null,"ValueMeaning":{"publicId":"13367925","version":"1","preferredName":"Stage I Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","longName":"13367925v1.00","preferredDefinition":"pT1-4, N0, M0, SX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2","conceptCode":"C198419","definition":"pT1-4, N0, M0, SX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9890792-E325-14A9-E053-731AD00AECF0","latestVersionIndicator":"Yes","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9890792-E326-14A9-E053-731AD00AECF0","beginDate":"2023-04-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-17","modifiedBy":"SOKKERL","dateModified":"2023-04-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13298955","version":"1","preferredName":"Toronto Childhood Cancer Stage Guidelines Neoplasm Stage","preferredDefinition":"A malignancy-specific staging system suitable for use by population registries for 16 of the most common childhood malignancies: acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, neuroblastoma, Wilms tumor, rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, osteosarcoma, Ewing sarcoma, retinoblastoma, hepatoblastoma, testicular and ovarian germ cell tumors, medulloblastoma, and ependymoma. The Guidelines include a two-tiered approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) and more detailed criteria for better-resourced registries (Tier 2). Tier 2 stage categories may be collapsed to Tier 1 categories to preserve comparability across registries. (http://www.iacr.com.fr/index.php?option=com_content&view=article&id=153&Itemid=657)_The extent of a cancer in the body.","longName":"13298955v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toronto Childhood Cancer Stage Guidelines","conceptCode":"C197985","definition":"A malignancy-specific staging system suitable for use by population registries for 16 of the most common childhood malignancies: acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, neuroblastoma, Wilms tumor, rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, osteosarcoma, Ewing sarcoma, retinoblastoma, hepatoblastoma, testicular and ovarian germ cell tumors, medulloblastoma, and ependymoma. The Guidelines include a two-tiered approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) and more detailed criteria for better-resourced registries (Tier 2). Tier 2 stage categories may be collapsed to Tier 1 categories to preserve comparability across registries. (http://www.iacr.com.fr/index.php?option=com_content&view=article&id=153&Itemid=657)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F872EA31-FFB1-5ACC-E053-731AD00A0400","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-03","modifiedBy":"COLBERTM","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F872EA31-FFB2-5ACC-E053-731AD00A0400","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-03","modifiedBy":"SOKKERL","dateModified":"2023-04-17","changeDescription":null,"administrativeNotes":"4/3/23 Created per Patrick Dunn CDDI SN entry 2165. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"13574489","version":"1","longName":"Childhood Cancer Data Initiative","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13594093","version":"1","longName":"Sample","context":"Pediatric Cancer"},{"publicId":"13596043","version":"1","longName":"Sample","context":"Pediatric Cancer"},{"publicId":"13596241","version":"1","longName":"Diagnosis","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"toronto_childhood_cancer_staging","type":"CCDI Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Stage","url":null,"context":"Pediatric Cancer"}],"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F872F64D-437F-5C97-E053-731AD00ADD2F","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-03","modifiedBy":"COLBERTM","dateModified":"2023-09-14","changeDescription":null,"administrativeNotes":"4/3/23 Created per Patrick Dunn CDDI SN entry 2165. mr","unresolvedIssues":null,"deletedIndicator":"No"}}